Nussbaum Ran
SEC CIK 1609805 · EDGAR
BoughtSold
Most active insiders at LBRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
Nussbaum Ran made no open-market trades at LBRX in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-09-16 | 2025-09-12 | LBRX | LB PHARMACEUTICALS INC | Nussbaum Ran | Dir | C - Cnv Deriv | — | +411.7K | 411.7K | New | — |
| DI | 2025-09-16 | 2025-09-12 | LBRX | LB PHARMACEUTICALS INC | Nussbaum Ran | Dir | P - Purchase | $15.00 | +1.00M | 1.41M | +243% | +$15.00M |
| D | 2025-06-06 | 2025-06-04 | KROS | Keros Therapeutics, Inc. | Nussbaum Ran | Dir, 10% | A - Grant | $0.00 | +5,250 | 5,250 | New | $0 |
| DI | 2023-02-28 | 2022-06-16 | URGN | UroGen Pharma Ltd. | Nussbaum Ran | Dir | M - OptEx | $5.00 | +2,211 | 1.44M | +0.2% | +$11.1K |
| DAI | 2023-02-28 | 2022-10-21 | URGN | UroGen Pharma Ltd. | Nussbaum Ran | Dir | M - OptEx | $5.94 | +48.0K | 1.49M | +3% | +$285.1K |
| DAI | 2023-02-28 | 2022-06-06 | URGN | UroGen Pharma Ltd. | Nussbaum Ran | Dir | M - OptEx | $5.00 | +1,030 | 1.43M | +0.1% | +$5,150 |
| DMI | 2022-11-30 | 2022-11-29 | KROS | Keros Therapeutics, Inc. | Nussbaum Ran | Dir, 10% | X - OptEx | $0.00 | -7,176 | 1.12M | -0.6% | $0 |
| DI | 2022-10-25 | 2022-10-21 | URGN | UroGen Pharma Ltd. | Nussbaum Ran | Dir | M - OptEx | $5.94 | +48.0K | 1.48M | +3% | +$285.1K |
| DI | 2022-08-25 | 2022-06-06 | URGN | UroGen Pharma Ltd. | Nussbaum Ran | Dir | M - OptEx | $5.00 | +1,030 | 1.43M | +0.1% | +$5,150 |
Purchase Sale Sale after option exercise All abbreviations